{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T10:40:10Z","timestamp":1748601610496,"version":"3.41.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,30]]},"DOI":"10.7759\/cureus.85074","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T10:00:21Z","timestamp":1748599221000},"source":"Crossref","is-referenced-by-count":0,"title":["The Significance of the Presence of Gilbert's Syndrome in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Retrospective Cohort Study"],"prefix":"10.7759","author":[{"given":"Arjuna  P","family":"De Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishanni","family":"Prabagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha S","family":"Wickramasinghage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aruni A","family":"Wanniarachchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dileepa  S","family":"Ediriweera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madunil A","family":"Niriella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hithanadura J","family":"De Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goae069","article-title":"Current epidemiology of chronic liver disease","volume":"12","author":"Manikat R","year":"2024","unstructured":"Manikat R, Ahmed A, Kim D. Current epidemiology of chronic liver disease. Gastroenterol Rep (Oxf). 2024, 12:goae069. 10.1093\/gastro\/goae069","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi ZM","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025, 31:S32-50. 10.3350\/cmh.2024.0431","journal-title":"Clin Mol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-95828-6_2","article-title":"The Burden of NAFLD Worldwide","author":"Younossi Z","year":"2020","unstructured":"Younossi Z, Henry L. The Burden of NAFLD Worldwide. Non-Alcoholic Fatty Liver Disease. Bugianesi E (ed): Springer, Cham, London; 2020. 15-24. 10.1007\/978-3-319-95828-6_2"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2024.07.019","article-title":"Metabolic dysfunction-associated steatotic liver disease: a pathophysiology and clinical framework to face the present and the future","volume":"35","author":"Corrao S","year":"2025","unstructured":"Corrao S, Calvo L, Gran\u00e0 W, et al.. Metabolic dysfunction-associated steatotic liver disease: a pathophysiology and clinical framework to face the present and the future. Nutr Metab Cardiovasc Dis. 2025, 35:103702. 10.1016\/j.numecd.2024.07.019","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref5","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease","author":"M\u00e9ndez-S\u00e1nchez N","year":"2025","unstructured":"M\u00e9ndez-S\u00e1nchez N, Qi X. Metabolic Dysfunction-Associated Steatotic Liver Disease. Springer, London; 2025."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2174\/092986712803341520","article-title":"Role of oxidative stress and molecular changes in liver fibrosis: a review","volume":"19","author":"S\u00e1nchez-Valle V","year":"2012","unstructured":"S\u00e1nchez-Valle V, Ch\u00e1vez-Tapia NC, Uribe M, M\u00e9ndez-S\u00e1nchez N. Role of oxidative stress and molecular changes in liver fibrosis: a review. Curr Med Chem. 2012, 19:4850-60. 10.2174\/092986712803341520","journal-title":"Curr Med Chem"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9547613","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","author":"Masarone M","year":"2018","unstructured":"Masarone M, Rosato V, Dallio M, et al.. Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxid Med Cell Longev. 2018, 9547613. 10.1155\/2018\/9547613","journal-title":"Oxid Med Cell Longev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202302447R","article-title":"Oxidative stress in metabolic dysfunction-associated steatotic liver disease (MASLD): how does the animal model resemble human disease?","volume":"38","author":"Jakubek P","year":"2024","unstructured":"Jakubek P, Kalinowski P, Karkucinska-Wieckowska A, et al.. Oxidative stress in metabolic dysfunction-associated steatotic liver disease (MASLD): how does the animal model resemble human disease?. FASEB J. 2024, 38:e23466. 10.1096\/fj.202302447R","journal-title":"FASEB J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.004","article-title":"Gilbert's syndrome revisited","volume":"79","author":"V\u00edtek L","year":"2023","unstructured":"V\u00edtek L, Tiribelli C. Gilbert's syndrome revisited. J Hepatol. 2023, 79:1049-55. 10.1016\/j.jhep.2023.06.004","journal-title":"J Hepatol"},{"key":"ref10","article-title":"Gilbert Syndrome","author":"Grant LM","year":"2024","unstructured":"Grant LM, Faust TW, Chandrasekar VT, John S. Gilbert Syndrome. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30959","article-title":"Crigler-Najjar syndrome type 1: pathophysiology, natural history, and therapeutic frontier","volume":"71","author":"Strauss KA","year":"2020","unstructured":"Strauss KA, Ahlfors CE, Soltys K, et al.. Crigler-Najjar syndrome type 1: pathophysiology, natural history, and therapeutic frontier. Hepatology. 2020, 71:1923-39. 10.1002\/hep.30959","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202405.0500.v1","article-title":"Gilbert\u2019s Syndrome: the good, the bad, and the ugly [PREPRINT]","volume":"9","author":"De Silva AP","year":"2024","unstructured":"De Silva AP, Nuwanshika N, Niriella MA, De Silva JH. Gilbert\u2019s Syndrome: the good, the bad, and the ugly [PREPRINT]. Med Pharmacol: Gastroenterol Hepatol. 2024, 9:20-5. 10.20944\/preprints202405.0500.v1","journal-title":"Med Pharmacol: Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2012.18.4.357","article-title":"Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease","volume":"18","author":"Jang BK","year":"2012","unstructured":"Jang BK. Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease. Clin Mol Hepatol. 2012, 18:357-9. 10.3350\/cmh.2012.18.4.357","journal-title":"Clin Mol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2008.02.011","article-title":"SDF-1alpha\/CXCR4 decreases endothelial progenitor cells apoptosis under serum deprivation by PI3K\/Akt\/eNOS pathway","volume":"201","author":"Zheng H","year":"2008","unstructured":"Zheng H, Dai T, Zhou B, Zhu J, Huang H, Wang M, Fu G. SDF-1alpha\/CXCR4 decreases endothelial progenitor cells apoptosis under serum deprivation by PI3K\/Akt\/eNOS pathway. Atherosclerosis. 2008, 201:36-42. 10.1016\/j.atherosclerosis.2008.02.011","journal-title":"Atherosclerosis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1515\/tjb-2016-0150","article-title":"Gilbert\u2019s syndrome: protective effect on endothelial dysfunction","volume":"41","author":"Serto\u011flu E","year":"2016","unstructured":"Serto\u011flu E, Tapan S, Do\u011fru T, et al.. Gilbert\u2019s syndrome: protective effect on endothelial dysfunction. Turk J Biochem. 2016, 41:451-8. 10.1515\/tjb-2016-0150","journal-title":"Turk J Biochem"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.59298\/IAAJSR\/2024\/112.5288","article-title":"Advances in laboratory diagnosis and clinical management of Gilbert disease: a comprehensive review","volume":"11","author":"Ukibe NR","year":"2024","unstructured":"Ukibe NR, Onwe CT, Onah CE, et al.. Advances in laboratory diagnosis and clinical management of Gilbert disease: a comprehensive review. IAA J Sci Res. 2024, 11:1-6. 10.59298\/IAAJSR\/2024\/112.5288","journal-title":"IAA J Sci Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164657","article-title":"Masld-related hepatocarcinoma: special features and challenges","volume":"13","author":"Yag\u00fce-Caballero C","year":"2024","unstructured":"Yag\u00fce-Caballero C, Casas-Deza D, Pascual-Oliver A, Espina-Cadena S, Arbones-Mainar JM, Bernal-Monterde V. Masld-related hepatocarcinoma: special features and challenges. J Clin Med. 2024, 13:4657. 10.3390\/jcm13164657","journal-title":"J Clin Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00396.2016","article-title":"Mice with hyperbilirubinemia due to Gilbert's syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPAR\u03b1","volume":"312","author":"Hinds TD Jr","year":"2017","unstructured":"Hinds TD Jr, Hosick PA, Chen S, Tukey RH, Hankins MW, Nestor-Kalinoski A, Stec DE. Mice with hyperbilirubinemia due to Gilbert's syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPAR\u03b1. Am J Physiol Endocrinol Metab. 2017, 312:E244-52. 10.1152\/ajpendo.00396.2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65481-4","article-title":"A Gilbert syndrome-associated haplotype protects against fatty liver disease in humanized transgenic mice","volume":"10","author":"Landerer S","year":"2020","unstructured":"Landerer S, Kalthoff S, Paulusch S, Strassburg CP. A Gilbert syndrome-associated haplotype protects against fatty liver disease in humanized transgenic mice. Sci Rep. 2020, 10:8689. 10.1038\/s41598-020-65481-4","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10091474","article-title":"Oxidative stress and related biomarkers in Gilbert's syndrome: a secondary analysis of two case-control studies","volume":"10","author":"Wagner KH","year":"2021","unstructured":"Wagner KH, Khoei NS, Hana CA, et al.. Oxidative stress and related biomarkers in Gilbert's syndrome: a secondary analysis of two case-control studies. Antioxidants (Basel). 2021, 10:1474. 10.3390\/antiox10091474","journal-title":"Antioxidants (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2012.18.4.383","article-title":"Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease","volume":"18","author":"Kwak MS","year":"2012","unstructured":"Kwak MS, Kim D, Chung GE, et al.. Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease. Clin Mol Hepatol. 2012, 18:383-90. 10.3350\/cmh.2012.18.4.383","journal-title":"Clin Mol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2011.11.017","article-title":"Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: a favorable endogenous response","volume":"45","author":"Kumar R","year":"2012","unstructured":"Kumar R, Rastogi A, Maras JS, Sarin SK. Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: a favorable endogenous response. Clin Biochem. 2012, 45:272-4. 10.1016\/j.clinbiochem.2011.11.017","journal-title":"Clin Biochem"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.03.047","article-title":"Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences","volume":"146","author":"Erlinger S","year":"2014","unstructured":"Erlinger S, Arias IM, Dhumeaux D. Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences. Gastroenterology. 2014, 146:1625-38. 10.1053\/j.gastro.2014.03.047","journal-title":"Gastroenterology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD to MASLD: A consensus-driven change in nomenclature","volume":"8","author":"Eslam M","year":"2023","unstructured":"Eslam M, Newsome PN, Anstee QM, et al.. MAFLD to MASLD: A consensus-driven change in nomenclature. Lancet Gastroenterol Hepato. 2023, 8:29-43. 10.1053\/j.gastro.2019.11.312","journal-title":"Lancet Gastroenterol Hepato"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update","volume":"75","author":"Berzigotti A","year":"2021","unstructured":"Berzigotti A, Tsochatzis E, Boursier J, et al.. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update. J Hepatol. 2021, 75:659-89. 10.1016\/j.jhep.2021.05.025","journal-title":"J Hepatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2018.1428526","article-title":"Diagnostic criteria and contributors to Gilbert's syndrome","volume":"55","author":"Wagner KH","year":"2018","unstructured":"Wagner KH, Shiels RG, Lang CA, Seyed Khoei N, Bulmer AC. Diagnostic criteria and contributors to Gilbert's syndrome. Crit Rev Clin Lab Sci. 2018, 55:129-39. 10.1080\/10408363.2018.1428526","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.040","article-title":"Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients","volume":"42","author":"Malaguarnera L","year":"2005","unstructured":"Malaguarnera L, Madeddu R, Palio E, Arena N, Malaguarnera M. Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients. J Hepatol. 2005, 42:585-91. 10.1016\/j.jhep.2004.11.040","journal-title":"J Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.655320","article-title":"Pregnancy-related hormones increase UGT1A1-mediated labetalol metabolism in human hepatocytes","volume":"12","author":"Khatri R","year":"2021","unstructured":"Khatri R, Fallon JK, Sykes C, et al.. Pregnancy-related hormones increase UGT1A1-mediated labetalol metabolism in human hepatocytes. Front Pharmacol. 2021, 12:655320. 10.3389\/fphar.2021.655320","journal-title":"Front Pharmacol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16770","article-title":"FibroScan-AST score for diagnosing fibrotic MASH: a systematic review and meta-analysis of diagnostic test accuracy studies","volume":"39","author":"Malandris K","year":"2024","unstructured":"Malandris K, Arampidis D, Mainou M, et al.. FibroScan-AST score for diagnosing fibrotic MASH: a systematic review and meta-analysis of diagnostic test accuracy studies. J Gastroenterol Hepatol. 2024, 39:2582-91. 10.1111\/jgh.16770","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/364923-the-significance-of-the-presence-of-gilberts-syndrome-in-patients-with-metabolic-dysfunction-associated-steatotic-liver-disease-masld-a-retrospective-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T10:00:22Z","timestamp":1748599222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/364923-the-significance-of-the-presence-of-gilberts-syndrome-in-patients-with-metabolic-dysfunction-associated-steatotic-liver-disease-masld-a-retrospective-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.85074","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}